IE
JAZZ icon

Israel Englander’s Jazz Pharmaceuticals JAZZ Stock Holding History

Israel Englander’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,900
Closed -$6.57M – 6101
2025
Q1 		$6.57M Buy
+52,900
New +$6.9M ﹤0.01% 2604
2024
Q2 		– Sell
-1,700
Closed -$205K – 6228
2024
Q1 		$205K Buy
+1,700
New +$208K ﹤0.01% 5368
2021
Q2 		– Sell
-2,000
Closed -$329K – 6789
2021
Q1 		$329K Buy
+2,000
New +$329K ﹤0.01% 5152
2015
Q1 		– Sell
-4,100
Closed -$671K – 3844
2014
Q4 		$671K Buy
+4,100
New +$681K ﹤0.01% 2794
2014
Q2 		– Sell
-2,600
Closed -$361K – 3646
2014
Q1 		$361K Buy
+2,600
New +$391K ﹤0.01% 2833
2013
Q3 		– Sell
-6,100
Closed -$419K – 3443
2013
Q2 		$419K Buy
+6,100
New +$373K ﹤0.01% 2417

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Israel Englander's JAZZ Position: Q2 2026 in Review

Israel Englander reduced its Jazz Pharmaceuticals (JAZZ) stake by 39% in Q2 2026, selling an estimated $109M and leaving 763,880 shares worth $184M. The position accounts for 0.07% of the portfolio, ranked #272.

Israel Englander first reported a position in JAZZ in Q2 2013 and has held it in 51 quarters since. The position peaked at $239M in Q1 2026. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Israel Englander held 763,880 shares of Jazz Pharmaceuticals worth $184M as of Q2 2026.
  • Israel Englander sold 498,631 Jazz Pharmaceuticals shares in Q2 2026, an estimated $109M.
  • Jazz Pharmaceuticals made up 0.07% of Israel Englander's portfolio in Q2 2026, its #272 holding.
  • Israel Englander first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Israel Englander's Jazz Pharmaceuticals position peaked at $239M in Q1 2026.
  • 640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.